ecNumber*2.1.1.1#specificActivity*-999#specificActivityMaximum*#commentary*assay#organism*Sus scrofa#literature*441252#!ecNumber*2.1.1.1#specificActivity*-999#specificActivityMaximum*#commentary*activity in different individuals, correlation with phenotypic differences#organism*Homo sapiens#literature*441254#!ecNumber*2.1.1.1#specificActivity*-999#specificActivityMaximum*#commentary*activity in male animals of different inbred strains#organism*Mus musculus#literature*441258#!ecNumber*2.1.1.1#specificActivity*-999#specificActivityMaximum*#commentary*study population, DNA analysis and allelic discrimination assay of the NNMT gene, distribution of nicotinamide N-methyltransferase genotypes in families, children carrying the NNMT A allele face additional risk of congenital heart defects (CHDs) in combination with peri-conception exposure to medicines and/or a low dietary nicotinamide intake#organism*Homo sapiens#literature*686485#!ecNumber*2.1.1.1#specificActivity*-999#specificActivityMaximum*#commentary*signal transducers and activators of transcription 3 (Stat3)-regulated genes analyzed, expression of NNMT in cancer cells, promoter activity determined after transfection experiments with NNMT promoter-luciferase reporter construct, real-time PCR, Western-Blot and immunohistochemistry, correlation between the expression of NNMT and activated Stat3 in colon cancer cells, NNMT determined as a Stat3-regulated gene and as a potential tumor marker#organism*Homo sapiens#literature*687897#!ecNumber*2.1.1.1#specificActivity*-999#specificActivityMaximum*#commentary*expression levels of NNMT in oral squamous cell carcinoma (OSCC), quantitative real-time PCR, Western-Blot and immunohistochemical analyses, upregulation in tumor cells, correlation between NNMT upregulation and favorable prognosis of oral squamous cell carcinoma patients#organism*Homo sapiens#literature*689036#!ecNumber*2.1.1.1#specificActivity*-999#specificActivityMaximum*#commentary*association between A/G single nucleotide polymorphism of NNMT gene and total homocysteine concentration in plasma of Japanese man analyzed, genotyping by PCR followed by melting curve analysis, NNMT genotype not determined as a strong determinant of total homocysteine concentration in plasma, modifying effect on plasma homocysteine concentration not excluded#organism*Homo sapiens#literature*690123#!ecNumber*2.1.1.1#specificActivity*-999#specificActivityMaximum*#commentary*quantitative enzyme activity analysis in 25 non-smalll cell lung cancer samples#organism*Homo sapiens#literature*733618#!ecNumber*2.1.1.1#specificActivity*0.0011#specificActivityMaximum*#commentary*Y20A mutant protein, pH 8.6, 37&deg;C#organism*Homo sapiens#literature*718914#!ecNumber*2.1.1.1#specificActivity*0.0042#specificActivityMaximum*#commentary*D197A mutant protein, pH 8.6, 37&deg;C#organism*Homo sapiens#literature*718914#!ecNumber*2.1.1.1#specificActivity*0.077#specificActivityMaximum*#commentary*Y20F mutant protein, pH 8.6, 37&deg;C#organism*Homo sapiens#literature*718914#!ecNumber*2.1.1.1#specificActivity*0.14#specificActivityMaximum*#commentary*S201A mutant protein, pH 8.6, 37&deg;C#organism*Homo sapiens#literature*718914#!ecNumber*2.1.1.1#specificActivity*0.15#specificActivityMaximum*#commentary*wild type protein, pH 8.6, 37&deg;C#organism*Homo sapiens#literature*718914#!ecNumber*2.1.1.1#specificActivity*0.18#specificActivityMaximum*#commentary*K100A/E101A/E103A mutant protein, pH 8.6, 37&deg;C#organism*Homo sapiens#literature*718914#!ecNumber*2.1.1.1#specificActivity*0.21#specificActivityMaximum*#commentary*S213A mutant protein, pH 8.6, 37&deg;C#organism*Homo sapiens#literature*718914#